Concurrent with our TMEM230-associated studies, specific human gene mutations were identified promoting aberrant TMEM230 protein structure formation in age-dependent neurodegeneration disorders, including Parkinson’s disease (PD) and Alzheimer’s disease (AD) [15,16,17]. This evidence concerns the gene TMEM230 and substance dependence.